Now Available

for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)1
Now Available Vyleesi™ (bremelanotide injection)
scroll down

With great pleasure, we announce the arrival of Vyleesi

The first and only as-needed treatment that has been FDA approved for low sexual desire and associated distress1